Bruker Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BRKRP | BIO | 49Z.F | BMRA | PACB | NCYT.L | |
|---|---|---|---|---|---|---|
| Market cap | — | 10.16B | 154.56M | 7.98M | 792.62M | 25.58M |
| P/E (TTM) | — | 48.2 | — | — | — | — |
| Forward P/E | — | 39.0 | — | 4.4 | -6.1 | -5.1 |
| Price/book | — | 1.4 | 0.1 | 2.2 | 141.7 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | +23.96% | +7.89% | −34.11% | +27.08% | −12.25% |
| Today | −7.00% | +1.35% | +3.30% | +2.06% | +4.51% | −1.49% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All BRKRP news ›Bruker Drops 9.5% Amid Sector-Wide Selling
Bruker Corporation plunged 9.5% on Friday, closing at $56.13 as a broad selloff hammered medical device sector peers across the board. The $8.6 billion comp... The post Bruker Drops 9.5% Amid Sector-Wide Selling first appeared on…
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
BioSpace Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter
Bruker, Sotera downgraded as J.P. Morgan reviews life sciences coverage
Bruker, Sotera downgraded at J.P. Morgan (BRKR:NASDAQ) Seeking Alpha J.P. Morgan downgraded Bruker Corporation (BRKR) and Sotera Health (SHC) on Wednesday as the brokerage reviewed its coverage of the life science tools & diagnostics space…
Bruker (NASDAQ:BRKR) Stock Keeps Neutral Rating at JPMorgan Chase & Co.
MarketBeat Bruker (NASDAQ:BRKR) Stock Keeps Neutral Rating at JPMorgan Chase & Co. - JPMorgan reaffirmed its “neutral” rating on Bruker and maintained a $60 price target, implying approximately 6.78% upside from the stock’s $56.
Bruker Corporation (NASDAQ:BRKR) Stock Has Average Target Price of $58.57 According to Brokerages
Posted by Mitch Edgeman on Oct 12th, 2026 Read Our Latest Analysis on Bruker The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st were issued a…
Bruker Gains 66.3% in a Year: What's Driving the Rally?
Bruker Corporation BRKR has witnessed strong momentum over the past year. Shares of the company have risen 66.3% compared with the industry’s 66.4% growth. The S&P 500 composite has increased 18.2% during the same time frame. With healthy…
Bruker Corp (BRKR) Shares Fall 5.3% -- GF Value Says Still Overvalued
On October 06, 2026, Bruker Corp BRKR shares fell 5.3% to a current price of $60.50, moving within a 52-week range of $32.37 to $66.98. This drop comes amidst a broader price movement, with the stock experiencing a year-to-date increase of…
Bruker (NASDAQ:BRKR) Stock Price Down 6.5% - Time to Sell?
Bruker Corporation (NASDAQ:BRKR - Get Free Report)'s stock price fell 6.5% during trading on Tuesday. The company traded as low as $59.59 and last traded at $59.7050. Approximately 430,729 shares changed hands during mid-day trading, a…
Why Bruker (BRKR) is a Top Momentum Stock for the Long-Term
Zacks Equity Research October 02, 2026 BRKR is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this Computer and Technology stock. BRKR has a Momentum Style Score of A, and shares are up 4.3%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com3
- tradingview.com2
- biospace.com1
- gurufocus.com1
- news.alphastreet.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.